Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Economist Predicts 'Gigantic Price Bubble' in Stock Market Amid Rising Valuations

Bibhu Pattnaik
September 13, 2025

David Rosenberg, founder of Rosenberg Research, has cautioned about a possible “gigantic price bubble” in the stock market.

This warning comes amidst concerns over the S&P 500’s forward returns due to current valuations. Rosenberg, who is recognized for his bearish economic perspective, voiced his apprehensions regarding the S&P 500’s future returns in light of the present valuations.

The Shiller cyclically adjusted price-to-earnings ratio of the index stands at approximately 37.5, making it the third-most expensive level in history, surpassed only by the peaks in 2021 and 2022.

As per the report by Business Insider, the valuations have traditionally served as dependable indicators of long-term stock market performance. According to Rosenberg’s data, which was quoted by the outlet, when the market hits such elevated valuation levels, one-year forward returns have typically been negative.

Also Read: Got $10,000? Here’s Where 6 Wall Street Titans Say You Should Invest

However, Rosenberg’s concerns extend beyond valuations. He also highlights a deteriorating economic environment, indicated by signs of decelerating job growth. Bureau of Labor Statistics data reveals that job growth has been under 100,000 per month for the past four months.

Rosenberg anticipates a further decline in the economic outlook, with initial jobless claims escalating to 263,000 last week. He proposes that the US economy might already be experiencing, or on the verge of, a downturn.

Despite these alarming indicators, stocks persist in achieving all-time highs. Rosenberg interprets this as a symptom of a price bubble. “We are in a gigantic price bubble that is ongoing. And you know it’s a price bubble when prices move up in the face of negative fundamentals,” he said.

“This is what a euphoric state looks like we’re seeing it in real time,” Rosenberg added.

Rosenberg’s warning comes at a time when the stock market continues to reach record highs despite the negative economic indicators.

This disconnect between the market performance and the economic fundamentals could potentially lead to a significant market correction.

Read Next

US Long Bond Slump Threatens Revival Of 60/40 Investment Strategy

Image: Shutterstock/Cherdchai101

Continue Reading...

Popular

Nebius Vs. Palantir: The AI Infrastructure War At 100x Sales

Wall Street's AI mania has sparked a battle between Nebius (NBIS) and Palantir (PLTR) as investors question where the true value of AI lies.

Bitcoin Hits $120,000 As JPMorgan Lifts Year-End Target To $165,000

Bitcoin (CRYPTO: BTC) broke above $120,000 in Thursday trading as JPMorgan Chase (NASDAQ:JPM) raised its year-end price

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

FAA Faces Furlough Of 11,000 Employees, Airlines Warn Of Delays Amid Shutdown Threat

11,000 FAA employees face potential furloughs due to government funding lapse. ATC and TSA workers would work without pay.

Palantir Stock Climbs Nearly 2% In Thursday Pre-Market: What's Going On?

Shares of Palantir Technologies Inc. (NASDAQ: PLTR) climbed 1.53% in Thursday pre-market after it signed a strategic deal worth billions with the U.K. government.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Bitcoin, Ethereum, Dogecoin Consolidate As XRP Tries To Push Higher

Cryptocurrency markets are trading sideways on Tuesday as investors position ahead of the Federal Reserve's interest rate decision.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Airbnb's Brian Chesky Agrees That Current AI Is 'Overrated,' Predicts 'Sudden' Changes Next Decade

Airbnb CEO Brian Chesky expressed his belief that daily life will remain relatively unchanged by artificial intelligence (AI) in the coming decade. However, he predicts a significant shift in the following decade.

Nvidia Is About to Shock the World: October 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

uCloudlink's GlocalMe Taps Into U.S. Pet Boom With PetPhone After Market Re-Entry

uCloudlink Group's consumer brand GlocalMe is making a renewed push into the U.S. with the launch of PetPhone, an AI-powered device designed to let pets and owners stay connected.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Big Tech's energy-hungry data centers could be bumped off grids during power emergencies

HARRISBURG, Pa. (AP) — With the explosive growth of Big Tech's data centers threatening to overload U.S. electricity grids, policymakers are taking a hard look at a tough-love solution: bumping the energy-hungry data centers off grids during power emergencies.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Anthony Scaramucci Says A Tesla–xAI Merger 'Feels Inevitable' As Shareholders Push For Investment In Grok Parent

Anthony Scaramucci said a Tesla–xAI merger "feels inevitable," amplifying shareholder pressure and investor debate as Musk backs closer ties between the EV maker and his $100 billion AI startup.

Trump's Immigration Policies Could 'Shrink' GDP Growth As US Population Projected To Decline, Warns CBO

The U.S. population growth is expected to decline at a faster rate than previously projected due to President Donald Trump's immigration policies, according to the Congressional Budget Office (CBO).

Another Gold High? Here's the Move Wall Street Is Missing ... - Ad

Gold just surged past $3,600, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.

What are Nexstar and Sinclair, the ABC affiliate owners who issued statements against Jimmy Kimmel

NEW YORK (AP) — spoke out against late night ahead of over comments he made about the killing of . Their comments highlight the influence local TV station owners have on national broadcasters such as Disney-owned ABC.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

Australia warns social media platforms against age verification for all ahead of a ban on children

MELBOURNE, Australia (AP) — Australian authorities said Tuesday that should not demand age verification for all account holders starting from December, when a having accounts goes into effect in the country.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Robert Kiyosaki Blasts Mutual Funds and ETFs as 'For Losers,' Backs Trump's XO for Alternative Investments

Robert Kiyosaki has expressed approval for President Trump's recent executive order, which he believes will democratize access to alternative investments for 401k investors.

AquaBounty Technologies Stock Explodes Over 98% After Hours: Here's Why

AquaBounty Technologies saw a massive 98.25% surge in after-hours trading to $2.26, following confirmation that it had met NASDAQ's minimum bid price requirement, resolving its earlier delisting risk.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI

This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.

Opendoor Stock Rallies On Expansion And Short Squeeze Hopes

Opendoor stock rallied on Wednesday after it announced an expansion of U.S. operations, but it didn't specify which operations.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Economists Warn 'Stagflation Is In The Room' Amid Interest Rate Cut News: 'The Fed Has No Idea Where Inflation Will Be,' Says Peter Schiff

Leading economists are reacting to the Federal Reserve's decision to cut interest rates by 25 basis points on Wednesday, with some lauding the central bank's independence, and others warning of difficult times ahead.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Why Redwire Stock Is Gaining Today

Redwire climbs about 4% after subsidiary Edge Autonomy wins a European NATO ally contract to supply Stalker Group 2 reconnaissance drone.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright finstrategist.com
Privacy Policy | Terms of Service